I am very happy to report that we just received an NIH grant award to develop our research on next generation bone grafts. The recognition from the NIH supports our confidence in the potential impact of our ideas on the future treatment of musculoskeletal disorders. The innovation of the proposal is the use of small signaling molecules, based on cyclic adenosine monophosphate (cyclic AMP) combined with matrices for engineering bone tissue. This award highlights the creativity and dedication of our scientists at the Institute for Regenerative Engineering including our the excellent work of co‒investigator, Dr. Kevin Wai Hong Lo.

Cato T. Laurencin, M.D., Ph.D.
University Professor
Albert and Wilda Van Dusen Distinguished Professor of Orthopaedic Surgery
Professor of Chemical, Materials and Biomolecular Engineering
Chief Executive Officer, Connecticut Institute for Clinical and Translational Science
Director, Institute for Regenerative Engineering

---